CO-IRBESARTAN Sandoz cpr pell 300/25 mg 98 pce

7680626400069 CH-62640 C09DA04 02.07.2.
CO-IRBESARTAN Sandoz cpr pell 300/25 mg 98 pce
CO-IRBESARTAN Sandoz cpr pell 300/25 mg 98 pce
1 / 2
google

Details

Product number
6264003
CPT
-
Packaging group
98
Unit
Tablette(n)
Composition
irbesartanum 300 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, lactosum monohydricum 16 mg, carmellosum natricum conexum corresp. natrium 1.19 mg, silica colloidalis anhydrica, hypromellosum, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, lactosum monohydricum 0.504 mg, talcum, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Co-Irbesartan Sandoz 300/25 mg, Filmtabletten
Filmtabletten
98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/08/2025
Patient information leaflet
Français
21/08/2025
Patient information leaflet
Italien
21/08/2025
Professional SmPC
Allemand
21/08/2025
Professional SmPC
Français
21/08/2025
Professional SmPC
Italien
21/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
16.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
1.19 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.504 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 64.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2014

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
62640
Drug name
Co-Irbesartan Sandoz, Filmtabletten
Galenic form
FILM
ATC Code
C09DA04
Authorization status
Z
Dispensation category
B
First authorization
06/11/2012
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
CO-IRBESARTAN Sandoz cpr pell 300/25 mg 98 pce
Description (DE)
CO-IRBESARTAN Sandoz Filmtabl 300/25 mg 98 Stk
Market launch
06/11/2012
Narcotic (BTM)
No

Original drug

CoAprovel, comprimés filmés
CHF 27.45
View original

Other packaging sizes

CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 28 pce
28 TABL
View
CO-IRBESARTAN Sandoz cpr pell 150/12.5 mg 98 pce
98 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/12.5 mg 28 pce
28 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/12.5 mg 98 pce
98 TABL
View
CO-IRBESARTAN Sandoz cpr pell 300/25 mg 28 pce
28 TABL
View